-
In late February 2026, U.S. Physical Therapy reported fourth-quarter and full-year 2025 results showing higher revenue but lower quarterly net income, while also announcing its CFO Carey Hendrickson will step down in April 2026 and be replaced on an interim basis by Senior Vice President of Finance and Accounting Jason Curtis.
-
Alongside a dividend increase, a new 10-year alliance folding ten clinics into a hospital system’s network highlighted management’s focus on long-term partnerships and capital returns even as leadership transitions.
-
We’ll now examine how the new 10-year hospital alliance and capital return moves affect U.S. Physical Therapy’s existing investment narrative.
Uncover the next big thing with 31 elite penny stocks that balance risk and reward.
To invest in U.S. Physical Therapy, you need to believe its outpatient clinic model can keep growing visits and earnings despite reimbursement and cost pressures. The latest results reinforce that revenue is expanding, but the drop in quarterly net income keeps margin resilience as the key near term catalyst and also the main risk to watch. The CFO transition and small dividend increase do not materially change that near term focus.
The new 10 year alliance that folds ten clinics into a hospital system’s network stands out as most relevant here, because it directly ties into the core volume growth and market access story. If these hospital partnerships support sustained patient throughput and help offset reimbursement pressure, they could be an important counterweight to softer quarterly profitability and rising labor costs.
Yet while these partnerships and capital returns may look reassuring on the surface, investors should still be aware of rising labor costs and clinician shortages that…
Read the full narrative on U.S. Physical Therapy (it’s free!)
U.S. Physical Therapy’s narrative projects $918.4 million revenue and $52.5 million earnings by 2028. This requires 8.3% yearly revenue growth and about a $17.9 million earnings increase from $34.6 million today.
Uncover how U.S. Physical Therapy’s forecasts yield a $106.83 fair value, a 29% upside to its current price.
One member of the Simply Wall St Community currently values U.S. Physical Therapy at US$106.83 per share, pointing to a relatively concentrated view of upside. You should weigh that against the ongoing reimbursement pressures that have already created a sizeable profit headwind and could influence how the business performs over time.